Matt Heck Co-Founder, President & Chief Executive Officer
Mr. Heck is the original founder, CEO and a member of the Board of Directors of Sentynl Therapeutics, Inc. Prior to Sentynl, Mr. Heck co-founded Victory Pharmaceuticals, Inc. and served as CEO and as a member of its Board of Directors. Prior to Victory, Mr. Heck served as Vice President of Sales at Biovail Pharmaceuticals, where he built and managed its U.S. commercial operations. Mr. Heck joined Biovail in 2000 through its acquisition of DJ Pharma, where Mr. Heck served on the founding management team in a variety of commercial capacities, including Vice President of Sales. Prior to DJ, Mr. Heck held a variety of positions in sales management, marketing and managed care functions at Dura Pharmaceuticals (acquired by Elan). Prior to joining Dura, Mr. Heck held multiple commercial roles at Dial Corporation. Mr. Heck earned his B.A. in Marketing from the University of South Carolina.
Daniel Stokely, CPA (Inactive) Executive Vice President & Chief Financial Officer
Mr. Stokely is the Executive Vice President and Chief Financial Officer. Previously, Mr. Stokely served in the roles of VP Finance / Chief Accounting Officer and Chief Financial Officer at Victory Pharmaceuticals. Prior to Victory, Mr. Stokely worked for Wireless Facilities, Inc. where he served in the role of Corporate Controller and Chief Accounting Officer. Previously, Mr. Stokely served in the role of Corporate Controller and Senior Director of Accounting for Dura Pharmaceuticals and its successor Elan Corporation. Mr. Stokely began his career as a CPA with Deloitte & Touche and received his B.S. in accounting from San Diego State University.
Michael Hercz, Esq. Senior Vice President, General Counsel & Chief Compliance Officer, head of Legal, Compliance, Regulatory Affairs & Quality
Mr. Hercz is Sentynl’s General Counsel and Chief Compliance Officer and oversees the company’s Legal, Compliance, Regulatory Affairs & Quality departments. Mr. Hercz brings more than 20 years of legal, regulatory, compliance and risk management experience to Sentynl. Prior to Sentynl, Mr. Hercz served as a Director in Deloitte & Touche’s Enterprise Risk Services Group where he advised Fortune 500 Life Sciences management teams on leading industry practices. Previously, Mr. Hercz was Vice President and Chief Compliance Officer of Victory Pharmaceuticals where he oversaw the company’s corporate compliance program and served as a member of the executive team. Prior to joining Victory, Michael spent nearly eight years with Amgen Inc. in a series of increasingly senior legal, regulatory, compliance and risk management roles. Prior to joining industry, Michael practiced law at the global law firm Akin, Gump, Strauss, Hauer & Feld LLP and at Hooper, Lundy & Bookman Inc. where he counseled Life Science industry clients on a broad range of legal and regulatory issues. Mr. Hercz earned his B.A. in Psychology from the University of Pennsylvania and his J.D. from the University of Southern California.
Darren Pincus Senior Vice President, Business Development
Mr. Pincus is the Senior Vice President, Business Development. Mr. Pincus is a highly experienced business development professional with a strong track record of successfully completed transactions. Prior to Sentynl, Mr. Pincus was Executive Director of Corporate and Business Development at Pacira Pharmaceuticals, where he was responsible for in-licensing, international out-licensing and pipeline initiatives. Previously, Mr. Pincus was Vice President of Corporate Development for EKR Therapeutics where he led the Corporate Development function. Prior to EKR, Mr. Pincus served in senior business development roles at Alpharma, Savient Pharma, and PLIVA / Odyssey Pharma. Mr. Pincus began his career in the Global Healthcare Corporate Finance practice of Arthur Anderson. Mr. Pincus earned his B.S. in Finance from the Pennsylvania State University.